Manufacturer
Aurobindo Pharma Limited, Unit-VII (SEZ)
Contents
Montelukast
Indication
Prophylaxis of exercise-induced asthma, Chronic asthma
Instruction
2-5 years as granules or chewable tab: 4 mg once daily, Doses to be taken 2 hours prior to exercise; no additional doses to be taken within 24 hours. Evaluate patient after 2-4 weeks of treatment.
Drug interaction
Decrease plasma concentration with CYP450 inducers (e.g. phenytoin, phenobarbital, rifampicin). Gemfibrozil may increase montelukast serum concentration.
Malaysia
